Matthew P. Young
2019
Compensation breakdown
Option Awards | $1,291,182 |
---|---|
Salary | $601,253 |
Stock Awards | $1,680,359 |
Other | $10,585 |
Total | $3,583,378 |
Young received $1.7M in stock awards, accounting for 47% of the total pay in 2019.
Young also received $1.3M in option awards, $601.3K in salary and $10.6K in other compensation.
Rankings
In 2019, Matthew P. Young's compensation ranked 3,385th out of 13,971 executives tracked by ExecPay. In other words, Young earned more than 75.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,385 out of 13,971 | 76th |
Division Manufacturing | 1,227 out of 5,701 | 79th |
Major group Chemicals And Allied Products | 417 out of 2,200 | 81st |
Industry group Drugs | 345 out of 1,886 | 82nd |
Industry Pharmaceutical Preparations | 258 out of 1,398 | 82nd |
Pay ratio
Matthew P. Young's Pay | $3,583,378 |
---|---|
Median Employee's Pay | $214,881 |
Pay Ratio | 17to 1 |
In 2019, the annual total compensation of Matthew P. Young was $3,583,378.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $214,881.
The ratio of Matthew P. Young's pay to the pay of median employee was therefore 17 to one.
Young's colleagues
We found six more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2019.
2019
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2019
Daniel Swisher
Jazz Pharmaceuticals
Chief Operating Officer
2019
Robert Iannone
Jazz Pharmaceuticals
Executive Vice President, Research and Development
2019
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2019
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
2019
Neena Patil
Jazz Pharmaceuticals